{"id":2749,"date":"2022-02-14T09:37:21","date_gmt":"2022-02-14T09:37:21","guid":{"rendered":"https:\/\/vs-a.fr\/?p=2749"},"modified":"2022-04-27T09:45:30","modified_gmt":"2022-04-27T09:45:30","slug":"viguie-schmidt-associes-a-a-r-p-i-advises-nextstage","status":"publish","type":"post","link":"https:\/\/vs-a.fr\/en\/viguie-schmidt-associes-a-a-r-p-i-advises-nextstage\/","title":{"rendered":"Vigui\u00e9 Schmidt &#038; Associ\u00e9s A.A.R.P.I. advises Nextstage"},"content":{"rendered":"<p>Vigui\u00e9 Schmidt &amp; Associ\u00e9s A.A.R.P.I. advised Nextstage AM in the frame of their \u20ac35.5m investment in EurobioNext, a joint venture with two reference shareholders of Eurobio Scientific and aiming at holding a 28.3% stake in Eurobio Scientific.<\/p>\n<p>Members of the team involved in the transaction:<\/p>\n<ul>\n<li><a href=\"https:\/\/vs-a.fr\/en\/team\/__trashed\/\">Nicolas Vigui\u00e9<\/a><\/li>\n<li><a href=\"https:\/\/vs-a.fr\/en\/team\/louis-chenard\/\">Louis Chenard<\/a><\/li>\n<li><a href=\"\/?p=641\">Christel Alberti<\/a><\/li>\n<li><a href=\"\/?p=701\">Virginie Viallard<\/a><\/li>\n<li><a href=\"https:\/\/vs-a.fr\/en\/team\/tanguy-grimald\/\">Tanguy Grimald<\/a><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&gt;<a href=\"https:\/\/vs-a.fr\/wp-content\/uploads\/2022\/04\/VSA-conseille-Nexstage_LJA152500.pdf\">Download the press release<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Vigui\u00e9 Schmidt &amp; Associ\u00e9s A.A.R.P.I. advised Nextstage AM in the frame of their \u20ac35.5m investment in EurobioNext, a joint venture with two reference shareholders of Eurobio Scientific and aiming at holding a 28.3% stake in Eurobio Scientific. Members of the team involved in the transaction: Nicolas Vigui\u00e9 Louis Chenard Christel Alberti Virginie Viallard Tanguy Grimald&#8230;  <a class=\"excerpt-read-more\" href=\"https:\/\/vs-a.fr\/en\/viguie-schmidt-associes-a-a-r-p-i-advises-nextstage\/\" title=\"Read Vigui\u00e9 Schmidt &#038; Associ\u00e9s A.A.R.P.I. advises Nextstage\">Read more &raquo;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-2749","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"_links":{"self":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts\/2749","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/comments?post=2749"}],"version-history":[{"count":3,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts\/2749\/revisions"}],"predecessor-version":[{"id":2752,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/posts\/2749\/revisions\/2752"}],"wp:attachment":[{"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/media?parent=2749"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/categories?post=2749"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vs-a.fr\/en\/wp-json\/wp\/v2\/tags?post=2749"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}